Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / An exploratory study evaluating the 30 medications most commonly associated with headaches in the FDA Adverse Event Reporting System.

< BACK TO ARCHIVE


Papers: 14 Jan 2023 - 20 Jan 2023


Human Studies


2023 Jan 18


Headache


http://www.ncbi.nlm.nih.gov/pubmed/36651638?dopt=Abstract

An exploratory study evaluating the 30 medications most commonly associated with headaches in the FDA Adverse Event Reporting System.

Authors

An exploratory study evaluating the 30 medications most commonly associated with headaches in the FDA Adverse Event Reporting System.
Musialowicz B, Kamitaki B, Zhang P
Headache. 2023 Jan 18.
PMID: 36651638.

Abstract

This project seeks to identify the top 30 drugs most commonly associated with headaches in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS), as well as their respective reporting odds ratios (RORs).
Read This Paper